Safety, PK and Efficacy of CT-707 in Combination With Toripalimab and Gemcitabine in Advanced Pancreatic Cancer
Status:
Recruiting
Trial end date:
2024-08-11
Target enrollment:
Participant gender:
Summary
This study will assess the safety, tolerability, pharmacokinetics and antineoplastic activity
of CT-707 in combination with toripalimab and gemcitabine in patients with advanced
pancreatic cancer